• December 2, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Animal & Dental Health Summit on Thursday, Dec. 11, in Boston, Mass. Paul Herendeen, Executive Vice President and Chief Financial Officer, and Clint Lewis, Executive Vice President and President, U.S. Operations, will represent the company and respond to questions from analysts. They are scheduled to present at 12:30 p.m. EST. The meeting is not scheduledmore...
  • December 1, 2014
    FLORHAM PARK, N.J., December 1, 2014 – Zoetis is pleased to announce that the American Animal Hospital Association (AAHA) has selected the company’s Pet Wellness Report® (PWR) as AAHA’s exclusive Preferred Business Provider for Health Risk Assessments in veterinary medicine. AAHA accredited hospitals are traditionally on the forefront of advancing new approaches to medical care for companion animals. The endorsement lends credibility to this innovative communication tool, which furthermore...
  • November 24, 2014
    QINGDAO, CHINA - November 24, 2014 - Zoetis, the Chinese Veterinary Medical Association (CVMA), and Kansas State University (KSU) signed a Memorandum of Understanding to work together and promote the Doctor of Veterinary Program (DVM) in China. This program aims to enhance veterinary services and veterinary training in the country by sharing the collective resources and providing other necessary support.The agreement was signed at the International Symposium on Veterinary Education held inmore...
  • November 24, 2014
    DURHAM, N.C. - November 24, 2014 – Zoetis Inc. today announced the reintroduction of Zoamix® (zoalene), a versatile synthetic anticoccidial for the prevention and control of coccidiosis in broilers and turkeys.“The U.S. poultry industry loses an estimated $600 million a year to coccidiosis[i], so the return of Zoamix could not be coming at a better time,” said Don Waldrip, DVM, DACPV, a senior technical services veterinarian with Zoetis.He noted that U.S. poultry producers have not seen a newmore...
  • November 24, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Roman Trawicki as President of its Global Manufacturing and Supply organization. With more than 20 years of broad, international experience in healthcare manufacturing and operations, Mr. Trawicki will oversee the company’s global manufacturing and supply network that produces more than 300 animal health product lines for the company. As the world leader in animal health, Zoetismore...
  • November 18, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS), the world’s leading animal health company, today hosted its first-ever Investor Day, discussing with investors and analysts the company’s leadership position in the animal health industry and the strategy and initiatives underway that will drive growth and create value for shareholders. The company also provided full-year 2015 financial guidance and outlined its longer term financial goals through 2017. “more...
  • November 18, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), the world’s leading animal health company, today announced that its Board of Directors has authorized a $500 million share repurchase program as part of its capital allocation plans. The shares are expected to be repurchased at the discretion of management, depending on market conditions and business needs. The authorization allows for repurchases to be conducted through open market or privately negotiated transactionsmore...
  • November 17, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million. Abbott Animal Health is a companion animal health business focused on the veterinary surgical suite. This acquisition will strengthen Zoetis’ companion animal product portfolio and expand its diagnostics business as more pets are being treated for pain and serious illnesses, such as cancer and diabetesmore...
  • November 14, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced that its Board of Directors has adopted a one-year shareholder rights plan (the “Plan”) and declared a dividend distribution of one preferred share purchase right (a “Right”) for each outstanding share of the Company’s common stock. The Plan will automatically expire on November 16, 2015, unless the Rights are earlier redeemed, exchanged or terminated. The Plan is intended to protect shareholdersmore...
  • November 13, 2014
    LONDON, UK – Nov. 13, 2014 - A consortium of academic and animal health industry partners in the UK, led by Zoetis Inc., is embarking on a pioneering 42-month project that will develop visual imaging methods and digital technologies to help producers improve the health and wellness of pig herds and enhance production efficiency.  The $3 million (USD) project, announced today, is funded by an Agri-Tech Catalyst Award from Innovate UK, the UK’s innovation agency.  The partners willmore...